| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911110 | Lung Cancer | 2014 | 8 Pages |
Abstract
Vx-001 vaccine is well tolerated and induced a TERT-specific immunological response, which was significantly correlated with improved clinical outcome.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Athanasios Kotsakis, Elisavet Papadimitraki, Eleni Kyriaki Vetsika, Despoina Aggouraki, Eleftheria Kleio Dermitzaki, Dora Hatzidaki, Nikolaos Kentepozidis, Dimitris Mavroudis, Vassilis Georgoulias,